Key Record Dates
ClinicalTrials.gov Identifier: | NCT03671148 |
---|---|
Brief Title: | A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) (KEEPsAKE2) |
First Submitted : | September 12, 2018 |
First Submitted that Met QC Criteria : | September 12, 2018 |
First Posted : | September 14, 2018 |
Results First Submitted : | February 1, 2022 |
Results First Posted with QC Comments : | February 25, 2022 |
Results First Submitted that Met QC Criteria : | February 28, 2022 |
Results First Posted : | March 2, 2022 |
Certification/Extension First Submitted : | June 7, 2021 |
Certification/Extension First Submitted that Met QC Criteria : | February 28, 2022 |
Certification/Extension First Posted : | March 2, 2022 |
Last Update Submitted that Met QC Criteria : | February 28, 2022 |
Last Update Posted : | March 2, 2022 |